Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice

Journal of Lipid Research

Volumn 48, Issue 5, 2007, Pages 1052-1061

  Lee, Ji Young ^a   Badeau, Robert M ^a   Mulya, Anny ^a   Boudyguina, Elena ^a   Gebre, Abraham K ^a   Smith, Thomas L ^a   Parks, John S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol; High density lipoproteins; Lecithin:cholesterol acyltransferase; Scavenger receptor class B type I; Sphingomyelin

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SCAVENGER RECEPTOR BI; SPHINGOMYELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION; HYPOLIPOPROTEINEMIA; IN VIVO STUDY; KNOCKOUT MOUSE; LIPID ANALYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; HUMANS; LECITHIN ACYLTRANSFERASE DEFICIENCY; LIPIDS; LIVER; MICE; MICE, KNOCKOUT; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RNA, MESSENGER;

EID: 34248179975     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600417-JLR200     Document Type: Article

References (53)

1. Barter, P. J. 1997. Inhibition of endothelial cell adhesion molecule expression by high density lipoproteins. Clin. Exp. Pharmacol. Physiol. 24: 286-287.
2. Parthasarathy, S., J. Barnett, and L. G. Fong. 1990. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044: 275-283.
3. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
4. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
5. Stein, Y., Y. Dabach, G. Hollander, G. Halperin, and O. Stein. 1983. Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim. Biophys. Acta. 752: 98-105.
6. Krieger, M. 1999. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem. 68: 523-558.
7. Krieger, M. 1998. The "best" of cholesterols, the "worst" of cholesterols: a tale of two receptors. Proc. Natl. Acad. Sci. USA. 95: 4077-4080.
8. Ueda, Y., L. Royer, E. Gong, J. Zhang, P. N. Cooper, O. Francone, and E. M. Rubin. 1999. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J. Biol. Chem. 274: 7165-7171.
9. Wang, N., T. Arai, Y. Ji, F. Rinninger, and A. R. Tall. 1998. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein apoB, low density lipoprotein apoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273: 32920-32926.
10. Kozarsky, K. F., M. H. Donahee, A. Rigotti, S. N. Iqbal, E. R. Edelman, and M. Krieger. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 387: 414-417.
11. Kozarsky, K. F., M. H. Donahee, J. M. Glick, M. Krieger, and D. J. Rader. 2000. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 20: 721-727.
12. Arai, T., N. Wang, M. Bezouevski, C. Welch, and A. R. Tall. 1999. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J. Biol. Chem. 274: 2366-2371.
13. Trigatti, B., H. Rayburn, M. Vinals, A. Braun, H. Miettinen, M. Penman, M. Hertz, M. Schrenzel, L. Amigo, A. Rigotti, et al. 1999. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. USA. 96: 9322-9327.
14. Rigotti, A., B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger. 1997. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA. 94: 12610-12615.
15. Braun, A., B. L. Trigatti, M. J. Post, K. Sato, M. Simons, J. M. Edelberg, R. D. Rosenberg, M. Schrenzel, and M. Krieger. 2002. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90: 270-276.
16. Huszar, D., M. L. Varban, F. Rinninger, R. Feeley, T. Arai, V. Fairchild-Huntress, M. J. Donovan, and A. R. Tall. 2000. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler. Thromb. Vasc. Biol. 20: 1068-1073.
17. Van Eck, M., J. Twisk, M. Hoekstra, B. T. Van Rij, C. A. Van der Lans, I. S. Bos, J. K. Kruijt, F. Kuipers, and T. J. Van Berkel. 2003. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J. Biol. Chem. 278: 23699-23705.
18. Yesilaltay, A., M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K. F. Kozarsky, and M. Krieger. 2006. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility. Endocrinology. 147: 1577-1588.
19. Ma, K., T. Forte, J. D. Otvos, and L. Chan. 2005. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models. Arterioscler. Thromb. Vasc. Biol. 25: 149-154.
20. Bouly, M., D. Masson, B. Gross, X. C. Jiang, C. Fievet, G. Castro, A. R. Tall, J. C. Fruchart, B. Staels, L. Lagrost, et al. 2001. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J. Biol. Chem. 276: 25841-25847.
21. Yamashita, S., D. L. Sprecher, N. Sakai, Y. Matsuzawa, S. Tarui, and D. Y. Hui. 1990. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J. Clin. Invest. 86: 688-695.
22. Oliveira, H. C., L. Ma, R. Milne, S. M. Marcovina, A. Inazu, H. Mabuchi, and A. R. Tall. 1997. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. Arterioscler. Thromb. Vasc. Biol. 17: 1045-1052.
23. Matsuura, F., N. Wang, W. Chen, X-c. Jiang, and A. R. Tall. 2006. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J. Clin. Invest. 116: 1435-1442.
24. Furbee, J. W., Jr., O. L. Francone, and J. S. Parks. 2001. Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human lecithin:cholesterol acyltransferase (LCAT). J. Lipid Res. 42: 1626-1635.
25. Carr, T. P., C. J. Andresen, and L. L. Rudel. 1993. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26: 39-42.
26. Timmins, J. M., J. Y. Lee, E. Boudyguina, K. D. Kluckman, L. R. Brunham, A. Mulya, A. K. Gebre, J. M. Coutinho, P. L. Colvin, T. L. Smith, et al. 2005. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115: 1333-1342.
27. Koritnik, D. L., and L. L. Rudel. 1983. Measurement of apolipoprotein A-I concentration in nonhuman primate serum by enzymelinked immunosorbent assay (ELISA). J. Lipid Res. 24: 1639-1645.
28. Parks, J. S., and A. K. Gebre. 1991. Studies on the effect of dietary fish oil on the physical and chemical properties of low density lipoproteins in cynomolgus monkeys. J. Lipid Res. 32: 305-315.
29. Fiske, C. H., and Y. SubbaRow. 1925. Colorimetric determination of phosphorus. J. Biol. Chem. 66: 357-400.
30. Lee, J. Y., J. M. Timmins, A. Mulya, T. L. Smith, Y. Zhu, E. M. Rubin, J. W. Chisholm, P. L. Colvin, and J. S. Parks. 2005. HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney. J. Lipid Res. 46: 2233-2245.
31. Stokke, K. T., and K. R. Norum. 1971. Determination of lecithin: cholesterol acyltransfer in human blood plasma. Scand. J. Clin. Lab. Invest. 27: 21-27.
32. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) method. Methods. 25: 402-408.
33. Zhao, Y., F. E. Thorngate, K. H. Weisgraber, D. L. Williams, and J. S. Parks. 2005. Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins. Biochemistry. 44: 1013-1025.
34. Chisholm, J. W., A. K. Gebre, and J. S. Parks. 1999. Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase. J. Lipid Res. 40: 1512-1519.
35. Lowry, O. H., N. J. Rosebrough, A. J. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
36. Lee, J. Y., L. Lanningham-Foster, E. Y. Boudyguina, T. L. Smith, E. R. Young, P. L. Colvin, M. J. Thomas, and J. S. Parks. 2004. Prebeta high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice. J. Lipid Res. 45: 716-728.
37. Mardones, P., V. Quinones, L. Amigo, M. Moreno, J. F. Miquel, M. Schwarz, H. E. Miettinen, B. Trigatti, M. Krieger, S. VanPatten, et al. 2001. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J. Lipid Res. 42: 170-180.
38. Subbaiah, P. V., and M. Liu. 1993. Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction. J. Biol. Chem. 268: 20156-20163.
39. Bolin, D. J., and A. Jonas. 1996. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J. Biol. Chem. 271: 19152-19158.
40. Ehnholm, S., K. W. van Dijk, B. Van't Hof, A. Van der Zee, V. M. Olkkonen, M. Jauhiainen, M. Hofker, L. Havekes, and C. Ehnholm. 1998. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J. Lipid Res. 39: 1248-1253.
41. Moore, R. E., M. Navab, J. S. Millar, F. Zimetti, S. Hama, G. H. Rothblat, and D. J. Rader. 2005. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ. Res. 97: 763-771.
42. Wolfrum, C., M. N. Poy, and M. Stoffel. 2005. Apolipoprotein M is required for pre[beta]-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11: 418-422.
43. Foger, B., M. Chase, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, et al. 1999. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274: 36912-36920.
44. Gruen, M. L., M. R. Plummer, W. Zhang, K. A. Posey, M. Linton, S. Fazio, and A. H. Hasty. 2005. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J. Lipid Res. 46: 2007-2014.
45. Fu, T., K. F. Kozarsky, and J. Borensztajn. 2003. Overexpression of SR-BI by adenoviral vector reverses the fibrate-induced hypercholesterolemia of apolipoprotein E-deficient mice. J. Biol. Chem. 278: 52559-52563.
46. Mardones, P., A. Pilon, M. Bouly, D. Duran, T. Nishimoto, H. Arai, K. F. Kozarsky, M. Altayo, J. F. Miquel, G. Luc, et al. 2003. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J. Biol. Chem. 278: 7884-7890.
47. Cheung, M. C., A. C. Wolf, K. D. Lum, J. H. Tollefson, and J. J. Albers. 1986. Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J. Lipid Res. 27: 1135-1144.
48. Urban, S., S. Zieseniss, M. Werder, H. Hauser, R. Budzinski, and B. Engelmann. 2000. Scavenger receptor BI transfers major lipoprotein-associated phospholipids into the cells. J. Biol. Chem. 275: 33409-33415.
49. Rodrigueza, W. V., S. T. Thuahnai, R. E. Temel, S. Lund-Katz, M. C. Phillips, and D. L. Williams. 1999. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J. Biol. Chem. 274: 20344-20350.
50. Rao, R., J. J. Albers, G. Wolfbauer, and H. J. Pownall. 1997. Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Biochemistry. 36: 3645-3653.
51. Albers, J. J., C. H. Chen, and J. L. Adolphson. 1981. Lecithin:cholesterol acyltransferase (LCAT) mass: its relationship to LCAT activity and cholesterol esterification rate. J. Lipid Res. 22: 1206-1213.
52. Parks, J. S., A. K. Gebre, and J. W. Furbee, Jr. 1998. Lecithin-cholesterol acyltransferase. Assay of cholesterol esterification and phospholipase A2 activities. In Methods in Molecular Biology. M. Doolittle and K. Reue, editors. Humana Press, Totowa, NJ. 123-131.
53. Foger, B., M. Chase, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, et al. 1999. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274: 36912-36920.